GlobeNewswire Inc | Sep 7, 2021 08:00AM EDT

September 07, 2021

PALO ALTO, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc.(Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announcedthat Vincerxs management team will participate in a fireside chat at the2021 Wells Fargo Virtual Healthcare Conference, to be heldSeptember 9-10, 2021.

Vincerx Fireside Chat Details Date: Thursday, September 9, 2021 Time: 4:40 PM Eastern Time Webcast: https://kvgo.com/wells-fargo/vincerx-pharma-inc-sept-2021

The presentation will be webcast live and archived for 90 days in the Investors section of the Companys website.

AboutVincerx Pharma, Inc.

Vincerx Pharma, Inc.(Vincerx) is a clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. Vincerx has assembled a management team of biopharmaceutical experts with extensive experience in building and operating organizations that develop and deliver innovative medicines to patients. Vincerxs current pipeline is derived from an exclusive license agreement with Bayer and includes a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation platform, which includes next-generation antibody-drug conjugates and innovative small molecule drug conjugates.

Contact Information

Bruce MackleLifeSci Advisors, LLC646-889-1200bmackle@lifesciadvisors.com